These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26840209)

  • 21. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association.
    Koie T; Ohyama C; Fujimoto H; Nishiyama H; Miyazaki J; Hinotsu S; Kikuchi E; Sakura M; Inokuchi J; Hara T; ; Ohyama C; Nishiyama H; Fujisawa M; Uemura H; Fujimoto H; Suzuki K; Eto M; Hara I; Matsubara A; Nonomura N; Nakanishi H; Koie T; Kanayama H; Miki T; Fukumori T; Naito S;
    Jpn J Clin Oncol; 2016 May; 46(5):468-74. PubMed ID: 26851754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: a prospective study.
    Kondo T; Hara I; Takagi T; Kodama Y; Hashimoto Y; Kobayashi H; Iizuka J; Omae K; Yoshida K; Tanabe K
    Int J Urol; 2014 May; 21(5):453-9. PubMed ID: 24754341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy.
    Fujita K; Ujike T; Nagahara A; Uemura M; Tanigawa G; Shimazu K; Fushimi H; Yamaguchi S; Nonomura N
    Int J Urol; 2015 May; 22(5):463-7. PubMed ID: 25631522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma.
    Kuroda K; Asakuma J; Asano T; Horiguchi A; Isono M; Tsujita Y; Sato A; Seguchi K; Ito K; Asano T
    Jpn J Clin Oncol; 2015 Jan; 45(1):103-10. PubMed ID: 25324479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial Comment from Dr Defidio to Thulium laser ablation facilitates retrograde intra-renal surgery for upper urinary tract urothelial carcinoma.
    Defidio L
    Int J Urol; 2018 Apr; 25(4):381-382. PubMed ID: 29577441
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial Comment from Dr Castelli to Thulium laser ablation facilitates retrograde intra-renal surgery for upper urinary tract urothelial carcinoma.
    Castelli E
    Int J Urol; 2018 Apr; 25(4):380-381. PubMed ID: 29520838
    [No Abstract]   [Full Text] [Related]  

  • 28. [Non-surgical treatment modalities available for the treatment of upper tract urothelial carcinomas: state-of-the-art review for the yearly scientific report of the French National Association of Urology].
    Audenet F; Rouprêt M; Houédé N; Colin P
    Prog Urol; 2014 Nov; 24(15):1030-40. PubMed ID: 25208728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update.
    Rouprêt M; Zigeuner R; Palou J; Boehle A; Kaasinen E; Sylvester R; Babjuk M; Oosterlinck W
    Eur Urol; 2011 Apr; 59(4):584-94. PubMed ID: 21269756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial Comment on: Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes by Metcalfe et al.
    Somani BK
    J Endourol; 2017 Sep; 31(9):954-955. PubMed ID: 28762779
    [No Abstract]   [Full Text] [Related]  

  • 31. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
    Gupta R; Paner GP; Amin MB
    Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan.
    Kikuchi E; Oya M
    Jpn J Clin Oncol; 2016 Aug; 46(8):768-74. PubMed ID: 27272173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidetector computed tomography urography (MDCTU) for diagnosing urothelial malignancy.
    Anderson EM; Murphy R; Rennie AT; Cowan NC
    Clin Radiol; 2007 Apr; 62(4):324-32. PubMed ID: 17331825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
    Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
    World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract.
    Kondo T; Tanabe K
    Int J Urol; 2012 Aug; 19(8):710-21. PubMed ID: 22515472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of upper urinary tract urothelial carcinoma.
    Sun M; Abdo A; Abdollah F; Schmitges J; Thuret R; Jeldres C; Shariat SF; Perrotte P; Karakiewicz PI
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1955-65. PubMed ID: 21110761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing oncologic outcomes in upper tract urothelial carcinoma.
    Hutchinson RC; Margulis V
    Minerva Urol Nefrol; 2016 Aug; 68(4):372-80. PubMed ID: 26756501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
    Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
    Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial comment to Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: a single institutional retrospective long-term follow-up study.
    Choi HY
    Int J Urol; 2010 Jul; 17(7):628. PubMed ID: 20590947
    [No Abstract]   [Full Text] [Related]  

  • 40. Editorial Comment from Dr Hatakeyama and Dr Ohyama to Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.
    Hatakeyama S; Ohyama C
    Int J Urol; 2021 Aug; 28(8):820. PubMed ID: 34013581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.